Key Insights

Highlights

Success Rate

79% trial completion

Published Results

41 trials with published results (19%)

Research Maturity

106 completed trials (49% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.0%

28 terminated out of 216 trials

Success Rate

79.1%

-7.4% vs benchmark

Late-Stage Pipeline

4%

9 trials in Phase 3/4

Results Transparency

39%

41 of 106 completed with results

Key Signals

41 with results79% success28 terminated

Data Visualizations

Phase Distribution

166Total
Not Applicable (85)
Early P 1 (8)
P 1 (33)
P 2 (31)
P 3 (9)

Trial Status

Completed106
Recruiting40
Terminated28
Unknown14
Active Not Recruiting13
Withdrawn9

Trial Success Rate

79.1%

Benchmark: 86.5%

Based on 106 completed trials

Clinical Trials (216)

Showing 20 of 20 trials
NCT07302347Phase 1RecruitingPrimary

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

NCT02479698Phase 2Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

NCT07252739Phase 2RecruitingPrimary

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

NCT03367156Phase 2Active Not Recruiting

Dexamethasone in Controlling Dyspnea in Patients With Cancer

NCT07630974Phase 1Not Yet RecruitingPrimary

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

NCT07247110Phase 1RecruitingPrimary

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

NCT01806129Not ApplicableActive Not RecruitingPrimary

Reproductive Health Program in Patients With Cancer

NCT04014231CompletedPrimary

Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer

NCT04181463Phase 2Not Yet RecruitingPrimary

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

NCT07600749Phase 1Not Yet RecruitingPrimary

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

NCT01552434Phase 1Terminated

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

NCT03568292Not ApplicableSuspendedPrimary

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

NCT06979596Phase 2RecruitingPrimary

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

NCT06941272Phase 1RecruitingPrimary

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

NCT04453072Not ApplicableRecruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

NCT06818643Phase 1Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

NCT02402244Recruiting

Project: Every Child for Younger Patients With Cancer

NCT02988271Not ApplicableActive Not Recruiting

Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress

NCT05823740Not ApplicableCompleted

Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

NCT03857620Not ApplicableActive Not RecruitingPrimary

Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer

Scroll to load more

Research Network

Activity Timeline